Real-time immunophenotypic shifts in pediatric B lymphoblastic leukemia providing implications for minimal residual disease detection [0.03%]
儿童B淋巴细胞急性白血病实时免疫表型变化对微小残留病检测具有指示意义
Omer Javed,Neelum Mansoor,Naeem Jabbar et al.
Omer Javed et al.
Objectives: Disease monitoring in acute leukemia management is crucial for risk stratification and chemotherapy response assessment. Minimal residual disease (MRD) testing is the most reliable tool, measuring antigenic ex...
Los cambios inmunofenotípicos en tiempo real en la leucemia linfoblástica pediátrica de tipo B tienen implicaciones para la detección de la enfermedad mínima residual [0.03%]
儿童B细胞急性淋巴细胞白血病实时免疫表型变化与微小残留病检测有关
Omer Javed,Neelum Mansoor,Naeem Jabbar et al.
Omer Javed et al.
Determinación de BRAF V600E por biopsia líquida en oncología de precisión [0.03%]
精密肿瘤学中通过液体活检确定BRAF V600E变异
Verónica A Alonso,Gabriela R Mendeluk
Verónica A Alonso
Impact of six sigma estimated using the Schmidt-Launsbyn vs. the Westgard equation in the Spanish type I EQA program [0.03%]
西班牙Schmidt-Launsby和Westgard公式估计的六西格玛在I型EQA项目中的影响分析
Fernando Marqués-García,Elisabeth González-Lao,Xavier Tejedor-Ganduxé et al.
Fernando Marqués-García et al.
Objectives: Six sigma methodology (SM) measures process performance using defects per million opportunities (DPMOs). SM has traditionally used the Westgard equation (WM), by which DPMOs are calculated indirectly. An alter...
Angel Díaz-Lagares,Wladimiro Jiménez
Angel Díaz-Lagares
Detection of Chlamydia trachomatis ompA DNA in urine by loop-mediated isothermal amplification (LAMP) assay [0.03%]
应用环介导等温扩增技术检测尿液中沙眼衣原体ompA基因
Hemali Attanayake,Charitha Goonasekara,Nalaka Abeygunasekera et al.
Hemali Attanayake et al.
Objectives: Efficient real-time PCR kits are commercially available for the detection of Chlamydia trachomatis (CT) genetic material, but at a price. As a result, cost-effective, sensitive and specific CT diagnostic tests...
Circulating tumor DNA in patients with cancer: insights from clinical laboratory [0.03%]
临床实验室中的肿瘤患者循环肿瘤DNA的新见解
Francisco J Illana,Esther Fernández-Galán,José Luis Muñoz-Bravo et al.
Francisco J Illana et al.
Blood-based circulating tumor DNA (ctDNA) analysis has emerged as a highly relevant non-invasive method for molecular profiling of solid tumors, offering valuable information about the genetic landscape of cancer. Somatic mutation analysis ...
Integrating ctDNA testing for EGFR analysis in advanced non-small cell lung cancer: strategies for clinical laboratories [0.03%]
基于NGS的血浆EGFR基因突变检测在晚期非小细胞肺癌中的临床应用策略
Esther Fernández-Galán,Joan Anton Puig-Butillé
Esther Fernández-Galán
Epidermal growth factor receptor gene (EGFR) molecular testing is essential for guiding targeted therapies in patients with advanced non-small cell lung cancer (NSCLC). Between 15 and 40 % of patients with NSCLC carry mutations in EGFR that...
Gabriela R Mendeluk,Verónica A Alonso
Gabriela R Mendeluk
Introduction: The BRAF V600E mutation is one of the most relevant genetic mutations in precision oncology. This variation is commonly found in several types of tumors, including melanoma, colorectal cancer, and thyroid ca...
ADN tumoral circulante en pacientes con cáncer: perspectivas desde el laboratorio clínico [0.03%]
肿瘤患者的循环肿瘤DNA：临床实验室视角展望
Francisco J Illana,Esther Fernández-Galán,José Luis Muñoz-Bravo et al.
Francisco J Illana et al.